Unknown NA INTERVENTIONAL 2-arm NCT03277001

Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD (SUPREME)

Multi-center、Randomize、Open、Non-inferiority Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD

Sponsor: Huashan Hospital

Conditions Acute Exacerbation Copd Venous Thromboembolism

Interventions Enoxaparin Rivaroxaban

Updated 6 times since 2017 Last updated: Sep 6, 2017 Started: Oct 1, 2017 Primary completion: Jul 31, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03277001, this NA trial focuses on Acute Exacerbation Copd and Venous Thromboembolism and remains ongoing. Sponsored by Huashan Hospital, it has been updated 6 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Feb 2020 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Oct 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Huashan Hospital

Data source: Huashan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China